PRO-BILAX DIN 02241874
Status: Cancelled Post Market
Holder: DISTRIBUTIONS MULTI-PRO INC.
Molecule: SENNOSIDES (CALCIUM SENNOSIDES A & B)
Health Canada record
| Active ingredient(s) | SENNOSIDES (CALCIUM SENNOSIDES A & B) 12 MG; CASCARA SAGRADA 67 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Human |
| ATC | A06AB20 CONTACT LAXATIVES IN COMBINATION |
| Original market date | 31-Aug-2000 |
| Current status date | 12-Aug-2004 |
| Source | Health Canada DPD |
Establishment licence of the holder
Distribution 2LG inc. — licence 3-002793, currently licensed, last inspection rating C (2025-02-05).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing SENNOSIDES (CALCIUM SENNOSIDES A & B)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02236802 | PHENOBILE | LES LABORATOIRES VACHON INC. | Tablet | SENNOSIDES (CALCIUM SENNOSIDES A & B) 12 MG; CASCARA SAGRADA 50 MG | Cancelled Post Market |
| 02291290 | SENNA-DOCUSATE TABLETS | INTERNATIONAL PHARMACEUTICAL GENERICS LTD | Tablet | SENNOSIDES (CALCIUM SENNOSIDES A & B) 8.6 MG; DOCUSATE SODIUM 50 MG | Cancelled Pre Market |
| 02236801 | VESILAX | FREGA INC. | Tablet | SENNOSIDES (CALCIUM SENNOSIDES A & B) 12 MG; CASCARA SAGRADA 50 MG | Cancelled Post Market |
| 02240986 | VESILAX+ | FREGA INC. | Tablet | SENNOSIDES (CALCIUM SENNOSIDES A & B) 12 MG; CASCARA SAGRADA 10 MG; BILE SALTS 65 MG | Cancelled Post Market |